Vor Biopharma Inc. - 8-K Filing
Vor Biopharma announced the immediate resignation of Andrew Levin, M.D., Ph.D., from its Board of Directors on July 6, 2026. On July 7, 2026, David Zaccardelli, Pharm.D., was appointed as an independent Class II director to fill the vacancy until the 2029 annual meeting or his successor is elected. Dr. Zaccardelli will receive a $40,000 annual cash retainer and equity compensation including initial stock options for up to 68,000 shares with a grant date fair value of $700,000. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $VOR